|
ZNF92 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.80190004531278E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.54310000333169E-08 |
| Normal-vs-Stage2 |
8.40330000000389E-05 |
| Normal-vs-Stage3 |
5.50629986051376E-10 |
| Normal-vs-Stage4 |
7.15538739370913E-12 |
| Stage1-vs-Stage2 |
2.771400E-01 |
| Stage1-vs-Stage3 |
8.915600E-02 |
| Stage1-vs-Stage4 |
5.811500E-04 |
| Stage2-vs-Stage3 |
3.669700E-02 |
| Stage2-vs-Stage4 |
2.255600E-03 |
| Stage3-vs-Stage4 |
9.835800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.41120004570894E-09 |
| Normal-vs-AfricanAmerican |
1.92324999999105E-05 |
| Normal-vs-Asian |
4.19269999829552E-08 |
| Caucasian-vs-AfricanAmerican |
7.651200E-01 |
| Caucasian-vs-Asian |
9.692600E-01 |
| AfricanAmerican-vs-Asian |
8.086800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.88319999594455E-08 |
| Normal-vs-Female |
2.45139997190336E-09 |
| Male-vs-Female |
6.785600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.18139997363454E-09 |
| Normal-vs-Age(41-60Yrs) |
5.06560005053558E-09 |
| Normal-vs-Age(61-80Yrs) |
7.50530004811623E-09 |
| Normal-vs-Age(81-100Yrs) |
3.558900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.394400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.683800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.971400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.954800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.515200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.251200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.877300E-03 |
| Classical-VS-Follicular |
7.320100E-02 |
| Classical-VS-Other |
9.705000E-01 |
| Classical-VS-Normal |
1.28479999972342E-08 |
| Tall-VS-Follicular |
3.046900E-04 |
| Tall-VS-Other |
3.794600E-01 |
| Tall-VS-Normal |
4.15170120504627E-11 |
| Follicular-VS-Other |
6.305800E-01 |
| Follicular-VS-Normal |
1.88599999995098E-06 |
| Other-VS-Normal |
2.060500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.66530147846811E-11 |
| Normal-vs-N1 |
4.39900338378152E-11 |
| N0-vs-N1 |
9.762500E-03 |
|
|
